Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice 247 Apr 16, 2021 35.50 0.00   
 24Storage 24STOR Apr 16, 2021 42.30 -1.40   
 2cureX 2CUREX Apr 16, 2021 19.14 +4.59   
 AAC Clyde Space AAC Apr 16, 2021 2.62 +0.96   
 AAK AAK Apr 16, 2021 200.50 -0.10   
 ABB ABB Apr 16, 2021 281.00 +1.48   
 Abelco Investment Group ABIG Apr 16, 2021 0.12 +0.85   
 Abera Bioscience ABERA Apr 16, 2021 13.00 0.00   
 ABG Sundal Collier Holding ABGO Apr 16, 2021 9.00 0.00   
 Abliva ABLI Apr 16, 2021 0.75 +0.53   
 Absolent Group ABSO Apr 16, 2021 400.00 +2.56   
 Absolicon ABSL Apr 16, 2021 135.50 -0.37   
 AcadeMedia ACAD Apr 16, 2021 89.50 +1.24   
 Acarix ACARIX Apr 16, 2021 1.67 +1.09   
 Acconeer ACCON Apr 16, 2021 44.70 -4.69   
 Acosense ACOS Apr 16, 2021 1.94 +3.19   
 AcouSort ACOU Apr 16, 2021 25.00 +0.40   
 ACQ Bure ACQSPAC 0.00 0.00   
 Acrinova A ACRIA Apr 16, 2021 11.62 0.00   
 Acrinova B ACRIB Apr 16, 2021 13.00 0.00   
 ACROUD ACROUD Apr 16, 2021 3.73 -5.57   
 Actic Group ATIC Apr 16, 2021 17.20 +3.30   
 Active Biotech ACTI Apr 16, 2021 1.48 +3.36   
 AcuCort ACUC Apr 16, 2021 4.87 -2.60   
 Adapteo ADAPT Apr 16, 2021 115.80 +0.70   
 AdderaCare ADDERA Apr 16, 2021 7.36 +1.66   
 AddLife B ALIFB Apr 16, 2021 212.60 +1.24   
 Addnode Group B ANODB Apr 16, 2021 281.50 +3.30   
 Addtech B ADDTB Apr 16, 2021 150.00 +2.04   
 ADDvise Group A ADDVA Apr 16, 2021 3.22 -2.42   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK